to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The venture capital climate improved in RTP in the first quarter, but biotech companies are still competing for dollars. Several RTP companies saw venture capital investment for development of pharmaceutical products and medical technologies. Read more to learn about the venture capital climate.
Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.
Health IT startup AutismSphere is replacing paper schedules with electronic ones to provide structure to kids with autism. Founder John Eder is testing the smart phone software in a North Carolina school district and hopes to expand. Read more about this healthcare business that helps kids with autism.
A startup company with a new way to make nanofibers sees many potential applications in the medical business. Xanofi has the technology to make strides in several industries, including the healthcare business.
A North Carolina startup is taking on the problem of counterfeit drugs. The company’s technology embeds a tiny tag into the medicine itself that allows for identification and authentication to fight fraudulent pharmaceuticals.
Innovations receiving funding at North Carolina State University include two projects with healthcare applications: work on a new Salmonella vaccine and wound-healing bandages.
At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.
A new marine biotech center will be established to help companies commercialize biotech-based products originating on the North Carolina coast. The North Carolina Biotechnology Center has awarded a $2.5 million, four-year grant for the center.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Cloud computing is becoming more popular with companies, including those in health IT. Here are some tips to keep in mind before signing with a cloud vendor.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.